Optimal lead time for treatment of infantile epileptic spasms syndrome-a secondary data analysis. [PDF]
Ge W, Pang P, Zhang Z, Wan L, Yang G.
europepmc +1 more source
Disparities in the utilization of genetic testing for non-acquired infantile epileptic spasms syndrome in a single healthcare center in North Carolina. [PDF]
Marzouki KE+10 more
europepmc +1 more source
Liquid Medication Dosing Errors: Comparison of a Ready-to-Use Vigabatrin Solution to Reconstituted Solutions of Vigabatrin Powder for Oral Solution. [PDF]
Gibson R, Klima R, Van Horn J.
europepmc +1 more source
Interdependence of clinical factors predicting cognition in children with tuberous sclerosis complex [PDF]
core +1 more source
The role of CSNK1A1 and its de novo mutations in infantile spasms syndrome. [PDF]
Ren D+16 more
europepmc +1 more source
An interpretable machine learning approach for predicting drug-resistant epilepsy in children with tuberous sclerosis complex. [PDF]
Fu J, Zhang G, Yang Z, Qin J.
europepmc +1 more source
New variants and genotype-phenotype correlation of <i>PPP3CA</i>-related developmental and epileptic encephalopathy. [PDF]
Wang T+9 more
europepmc +1 more source
Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy. [PDF]
Samanta D.
europepmc +1 more source